Grief drug trial stalls: naltrexone study halted after just 7 participants
NCT ID NCT06140420
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tested whether the drug naltrexone could help people with prolonged grief disorder, a condition where intense grief lasts for a long time. Only 7 people took part, and the study was stopped early. Participants took the drug or a placebo for 8 weeks and had monthly check-ins to measure their grief symptoms and social connections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACEBO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Tech Health Science Center
Lubbock, Texas, 79409, United States
Conditions
Explore the condition pages connected to this study.